Literature DB >> 3162810

Quantitative study of doxorubicin in living cell nuclei by microspectrofluorometry.

M Gigli1, S M Doglia, J M Millot, L Valentini, M Manfait.   

Abstract

Doxorubicin-DNA association has been studied by quantitative microspectrofluorometry. Fluorescence emission spectra from a microvolume of single living cell nuclei treated with doxorubicin have been analyzed in terms of difference in spectral shape and fluorescence yield between free and DNA-bound drug. Contribution of each spectral component to the total signal was calculated by least-squares linear regression. With this method of analysis, total drug concentration has been determined with an error of less than 10%. Moreover, the uptake into the nucleus has been studied in a non destructive way, avoiding use of 14C-labelled drug. Kinetic studies of drug accumulation into the nuclei were conducted on sensitive and resistant cells.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3162810     DOI: 10.1016/0167-4781(88)90068-1

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  19 in total

1.  Locating of nucleic acid intercalators in yeast cells by image analysis combined fluorescence microscopy.

Authors:  Evgeny O Puchkov; Millicent McCarren
Journal:  J Fluoresc       Date:  2010-12-03       Impact factor: 2.217

2.  Stability of adriamycin-induced DNA adducts and interstrand crosslinks.

Authors:  A van Rosmalen; C Cullinane; S M Cutts; D R Phillips
Journal:  Nucleic Acids Res       Date:  1995-01-11       Impact factor: 16.971

3.  Localization and molecular interactions of mitoxantrone within living K562 cells as probed by confocal spectral imaging analysis.

Authors:  A Feofanov; S Sharonov; I Kudelina; F Fleury; I Nabiev
Journal:  Biophys J       Date:  1997-12       Impact factor: 4.033

4.  Analysis of proteome changes in doxorubicin-treated adult rat cardiomyocyte.

Authors:  Suresh N Kumar; Eugene A Konorev; Deepika Aggarwal; Balaraman Kalyanaraman
Journal:  J Proteomics       Date:  2011-02-19       Impact factor: 4.044

5.  Molecular structure of the halogenated anti-cancer drug iododoxorubicin complexed with d(TGTACA) and d(CGATCG).

Authors:  I Berger; L Su; J R Spitzner; C Kang; T G Burke; A Rich
Journal:  Nucleic Acids Res       Date:  1995-11-11       Impact factor: 16.971

6.  Bis-daunomycin hydrazones: interactions with DNA.

Authors:  D R Phillips; R T Brownlee; J A Reiss; P A Scourides
Journal:  Invest New Drugs       Date:  1992-07       Impact factor: 3.850

7.  Use of oligonucleotides to define the site of interstrand cross-links induced by Adriamycin.

Authors:  S M Cutts; D R Phillips
Journal:  Nucleic Acids Res       Date:  1995-07-11       Impact factor: 16.971

8.  A cell fractionation approach for the quantitative analysis of subcellular drug disposition.

Authors:  Muralikrishna Duvvuri; Wenhong Feng; Amanda Mathis; Jeffrey P Krise
Journal:  Pharm Res       Date:  2004-01       Impact factor: 4.200

9.  Multiscale kinetic modeling of liposomal Doxorubicin delivery quantifies the role of tumor and drug-specific parameters in local delivery to tumors.

Authors:  B S Hendriks; J G Reynolds; S G Klinz; E Geretti; H Lee; S C Leonard; D F Gaddy; C W Espelin; U B Nielsen; T J Wickham
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2012-11-21

10.  Detection of Adriamycin-DNA adducts by accelerator mass spectrometry at clinically relevant Adriamycin concentrations.

Authors:  Kate E Coldwell; Suzanne M Cutts; Ted J Ognibene; Paul T Henderson; Don R Phillips
Journal:  Nucleic Acids Res       Date:  2008-07-16       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.